Clinical Trials Directory

Trials / Completed

CompletedNCT01131754

Heparin 100U/L for Prevention of PVC Complications

STUDIO CLINICO RANDOMIZZATO SULL'UTILIZZO DI EPARINA PER LA PROFILASSI DELLA TROMBOFLEBITE DA CATETERE VENOSO PERIFERICO

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
214 (actual)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Flushes with saline solution are used for maintaining patency of peripheral intermittent intravenous catheters in many institution based on the results of previous studies showing that 10 U heparin/mL is not better than saline in this respect. The latest meta-analysis investigated also safety and efficacy of heparin concentrations of 100 U/ml used as an intermittent flush, but no firm conclusion was reached because of limitations of the few available studies.

Conditions

Interventions

TypeNameDescription
OTHERheparin 100U/L flushesperipheral venous catheter flushing with 3 mL of a 100 U heparin/mL normal saline from mono-use vial (Epsodilave, Mayne Pharma, Naples, Italy) at the end of each drug infusion. Independently from the number of drug infusions, all patients will receive at least two catheter flushes every day.

Timeline

Start date
2007-06-01
Primary completion
2009-08-01
Completion
2009-09-01
First posted
2010-05-27
Last updated
2010-06-15

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01131754. Inclusion in this directory is not an endorsement.

Heparin 100U/L for Prevention of PVC Complications (NCT01131754) · Clinical Trials Directory